Neuca SA
WSE:NEU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Footway Group AB
STO:FOOT PREF
|
SE |
Neuca SA
Interest Expense
Neuca SA
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Neuca SA
WSE:NEU
|
Interest Expense
zł51m
|
CAGR 3-Years
6%
|
CAGR 5-Years
36%
|
CAGR 10-Years
16%
|
|
Neuca SA
Glance View
NEUCA SA engages in the wholesale of pharmaceutical products. The company is headquartered in Torun, Woj. Kujawsko - Pomorskie and currently employs 3,852 full-time employees. The company went IPO on 2004-09-30. The firm is mainly involved in the distribution of drugs to pharmacies. The company also operates in other sectors of the health market, such as production of drugs, supplements and cosmetics under its own brand, clinical trials, telemedicine, Information Technology (IT) solutions and e-commerce in the health care industry.
See Also
What is Neuca SA's Interest Expense?
Interest Expense
51m
PLN
Based on the financial report for Dec 31, 2025, Neuca SA's Interest Expense amounts to 51m PLN.
What is Neuca SA's Interest Expense growth rate?
Interest Expense CAGR 10Y
16%
Over the last year, the Interest Expense growth was -25%. The average annual Interest Expense growth rates for Neuca SA have been 6% over the past three years , 36% over the past five years , and 16% over the past ten years .
